This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_FEM_GENITAL_NOS_EXALLC for full statistics.
Carcinoma in situ of other/unspecified female genital organs
CD2_INSITU_FEM_GENITAL_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
18 |
4. Check minimum number of eventsNone |
18 |
5. Include endpointsNone |
18 |
6. Filter based on genotype QC (FinnGen only) |
18 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D07
- Name in latin
- Carcinoma in situ organorum genitalium femininorum aliorum sive non specificatorum
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other/unspecified female genital organs
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other/unspecified female genital organs
- Carcinoma in situ of other and unspecified genital organs
- Carcinoma in situ of other and unspecified genital organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 18 | 18 | - |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | - |
| Median age at first event (years) | 47.85 | 47.85 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
10
45
3.72
1.97
1.6
2.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
5
14
4.51
1.74
3.2
5.2
u/ml
46.8
89.4
—
5
14
(3042936) Bacteria identified in Isolate by Culture
5
15
4.18
1.64
2.0
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
51
2.52
1.19
2.6
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11
71
2.40
1.07
5.1
4.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
8
108
0.54
0.66
7.0
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
6
36
1.99
0.65
3.0
2.7
mmol/l
8.6
7.7
—
6
29
(40761536) Microorganisms panel - Urine sediment
0
20
0.00
0.65
0.0
3.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
48
1.74
0.56
3.1
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
31
1.84
0.48
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
33
1.71
0.46
1.6
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
6
44
1.54
0.39
2.0
3.2
—
7.4
—
0
12
(3044889) 12 lead EKG panel
12
102
1.53
0.33
3.4
3.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
6
48
1.37
0.24
1.5
2.3
u/l
52.0
53.1
—
6
43
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
11
0.00
0.22
0.0
1.9
—
—
—
0
0
(3000492) Spirometry study
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
0
11
0.00
0.22
0.0
4.6
—
230.8
—
0
11
(3004588) Protein electrophoresis panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.5
—
66.2
—
0
10
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
2.3
—
84.8
—
0
12
(3017732) Neutrophils [#/volume] in Blood
0
12
0.00
0.22
0.0
2.3
—
3.6
—
0
12
(3021589) Normoblasts [#/volume] in Blood
5
67
0.65
0.22
6.2
8.8
e9/l
0.0
0.0
—
5
59
(3001122) Ferritin [Mass/volume] in Serum or Plasma
8
65
1.41
0.22
1.8
3.0
ug/l
46.7
59.4
—
8
65
(3037467) Urinalysis macro (dipstick) panel - Urine
10
112
0.76
0.21
3.3
4.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
0
14
0.00
0.21
0.0
3.1
—
1.2
—
0
14
(3000494) Fungus identified in Specimen by Culture
0
14
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
9
78
1.31
0.20
4.4
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
42
1.26
0.11
1.2
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5
44
1.19
0.11
2.6
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
5
59
0.79
0.10
6.8
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
10
92
1.19
0.09
3.1
3.5
mmol/l
6.3
6.3
—
10
84
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
10
94
1.14
0.09
7.5
6.9
umol/l
9.4
9.5
—
10
85
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
6
0.00
0.00
0.0
1.0
—
1.0
—
0
6
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
6
0.00
0.00
0.0
5.0
—
45.3
—
0
6
(3013650) Neutrophils [#/volume] in Blood by Automated count
9
93
0.94
0.00
10.4
11.5
e9/l
3.9
4.1
—
9
83
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
1.4
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
6.3
—
0
6
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.0
—
0
5
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
71
0.98
0.00
3.6
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
7
0.00
0.00
0.0
1.3
—
4.9
—
0
7
(3001604) Monocytes [#/volume] in Blood
8
76
1.09
0.00
4.0
5.8
e9/l
0.6
0.6
—
8
71
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
0.2
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
11
109
1.02
0.00
3.8
3.0
u/l
39.3
44.4
0.15
11
104
(3000330) Specific gravity of Urine by Test strip
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
9.6
—
0
5
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
91.7
—
0
5
(3027315) Oxygen [Partial pressure] in Blood
0
7
0.00
0.00
0.0
1.3
—
9.6
—
0
7
(3023520) Reticulocytes [#/volume] in Blood
0
7
0.00
0.00
0.0
7.9
—
75.7
—
0
7
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.2
—
66.0
—
0
5
(3015736) pH of Urine
7
70
1.00
0.00
2.3
3.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010421) pH of Blood
0
7
0.00
0.00
0.0
1.4
—
7.4
—
0
7
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
6
57
1.08
0.00
6.3
2.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
4.3
—
0
5
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
3.8
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
108.6
—
0
5
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.9
—
4.5
—
0
9
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.3
—
23.8
—
0
8
(3027944) Amphetamines [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
3.1
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_FEM_GENITAL_NOS – Carcinoma in situ of other/unspecified female genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).